Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)
Common Stock
Additional Paid-in Capital
Deficit Accumulated During the Development Stage
Total
Beginning Balance, Amount at Dec. 31, 2012 $ 143,668 $ 79,340,666 $ (82,381,854) $ (2,897,520)
Beginning Balance, Shares at Dec. 31, 2012 143,667,570      
Common stock issued upon exercise of warrants and options, net Amount 22,869 6,579,231   6,602,100
Common stock issued upon exercise of warrants and options, net Shares 22,868,662      
Common stock issued upon exercise of warrants and options, Price Per Share $0.25-$0.98      
Common stock issued for services, Amount 50 48,950   49,000
Common stock issued for services, Shares 50,000      
Common stock issued for services, Price Per Share $0.98      
Common stock issued to employees and directors for compensation, Amount 325 369,788   370,113
Common stock issued to employees and directors for compensation, Shares 325,455      
Common stock issued to employees and directors for compensation, Price Per Share $1.09-$1.71      
Fair value of options and warrants issued as compensation   129,622   129,622
Fair value of options and warrants issued to consultants   101,819   101,819
Net loss     (2,646,485) (2,646,485)
Ending Balance, Amount at Sep. 30, 2013 $ 166,912 $ 87,930,711 $ (85,028,339) $ 3,069,284
Ending Balance, Shares at Sep. 30, 2013 166,911,687